Becton, Dickinson and Company Prices Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock Post author:Sam Post published:May 10, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like 3 Cancer Biotechs to Watch at ASCO May 4, 2017 Generation Bio Raises $100 Million Series B to Finance Non-Viral Gene Therapy Program February 26, 2018 The Medicines Company Slashes Hundreds of Jobs in Restructuring October 24, 2017
Generation Bio Raises $100 Million Series B to Finance Non-Viral Gene Therapy Program February 26, 2018